Abstract
Sensitivity of 100 enterococcal strains isolated from faeces in premature born unit to 15 antimicrobial agents has been studied. 33 strains of Enterococcus faecalis, 61 strains of Enterococcus faecium, 4 strains of Enterococcus casseliflavus and 2 strains of Enterococcus durans were included in this study. MICs to ampicillin, gentamicin, streptomycin, vancomycin, teicoplanin, chloramphenicol, tetracycline, rifampicin, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin, quinupristin, dalfopristin and quinupristin/dalfopristin were detected by agar dilution method. 53% of strains were resistant to ampicillin, 44 and 39% – to gentamicin and streptomycin, 50, 71 and 93% were resistant to chloramphenicol, tetracycline and rifampicin, respectively. There were no strains fully resistant to vancomycin and teicoplanin. Generally E. faecium was more resistant than other enterococci to most of tested antibiotics with exception of quinupristin/dalfopristin where E. faecalis was more resistant.
-
1.
Facklam R.R., Sahw D.F., Teixeira L.M. Enterococcus. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H., editors. Manual of Clinical Microbiology. 7th ed. Washington: ASM Press; 1999. p. 297-306.
-
2.
Identification of Streptococci and Streptococcus-like bacteria. In: Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P.C., Winn W.C., editors. Diagnostic Microbiology. 5th ed. Philadelphia: Lippincott-Raven Publishers; 1997. p. 603-51.
-
3.
Moellering RC. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell G.L., Bennett J.E., Dolin R., editors. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 2147-56.
-
4.
English B.K., Shenep J.L. Enterococcal and viridans streptococcal infections. In: Feigin R.D., Cherry J.D., editors. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: W.B. Saunders; 1998. p. 1106-29.
-
5.
McCarthy A.E., Victor G., Ramotar K., Toye B. Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital. J Clin Microbiol 1994;11:2671-6.
-
6.
Gordts B., van Landuyt H., Ieven M., Vandamme P., Goossens H.. Vancomycin-resistant enterococci colonising the intestinal tracts of hospitalised patients. J Inf Dis 1995;11:2842-6.
-
7.
Jordens J.Z., Bates J., Griffiths D.T. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994;34:515-28.
-
8.
Padiglione A.A., Grabsch E.A., Olden D., Hellard M., Sinclair M.I., Fairley C.K., Grayson M.L. Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Infect Dis 2000;6:534-6.
-
9.
Miedema C.J., Kerkhof M., Arends J.P., Bergman K.A., Kimpen J.L. Risk factors for colonization with enterococci in a neonatal intensive care unit. Clin Microbiol Infect Dis 2000; 6:53.
-
10.
Christie C., Hammond J., Reising S., Patterson J.E. Clinical and molecular epidemiology of enterococcal bacteremia in pediatric teaching hospital. J Pediatr 1994; 125:392-9.
-
11.
Dobson S.R., Baker C.J. Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics 1990; 85:165-71.
-
12.
Wells C.L., Juni B.A., Cameron S.B., Mason K.R., Dunn D.L., Ferrieri P., Rhame F. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995; 21:45-50.
-
13.
Pallares R., Pujol M., Pena C., Ariza J., Martin R., Gudiol F. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. Arch Intern Med 1993; 153:1581-6.
-
14.
Сидоренко С.В., Резван С.П., Грудинина С.А., Кротова Л.А., Стерхова Г.В. Результаты многоцентрового исследования антибиотикочувствительности энтерококков. Антибиотики и химиотер. 1998; 43(9):9-17.
-
15.
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - fifth edition M7-A5. MIC testing supplemental tables. NCCLS, Villanova, PA; 2000. p. 26-9.
-
16.
Bonten M.J., Gaillard C.A., Van Tiell F.H., van der Geest S., Stobberingh E.E. Colonisation and infection with Enterococcus faecalis in intensive care units: the role of antimicrobial agents. Antimicrob Agents Chemother 1995;12:2783-6.
-
17.
Schouten M.A., Voss A., Hoogkamp-Korstanje J.A.A., The European VRE Study Group. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. Antimicrob Agent Chemother 1999; 43:2542-6.
-
18.
Martines-Martinez L., Joyanes P., Pascual A., Terrero E., Perea E.J. Activity of eight fluoroquinolones against enterococci. Clin Microbiol Infect 1997; 3:497-9.
-
19.
Tankovic J. Developement of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene. Antimicrob Agents Chemother 1996;11:2558 - 61
-
20.
Williams J.D., Maskell J.P., Whiley A.C., Sefton A.M. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. J Antimicrob Chemother 1997; 39:41-6.